Acne and Acneiform Eruptions

The document reviewed various forms of acne and acneiform eruptions, their causes, symptoms, and treatments, emphasizing the importance of early intervention to prevent scarring and psychosocial impacts. It covered acne vulgaris, affecting 40-50 million people annually in the USA, and its persistence into adulthood, particularly in women. The pathogenesis involved factors like altered follicular keratinization and Propionibacterium acnes colonization. Treatments included topical retinoids, antibiotics, hormonal therapy, and isotretinoin, with considerations for pregnancy safety. The document also explored acne-associated syndromes and severe forms like acne conglobata, highlighting the psychological impact and treatment options such as isotretinoin and anti-inflammatory therapies. Additionally, it discussed rosacea, its subtypes, and management strategies, as well as the challenges of treating acne during pregnancy, recommending safer options like erythromycin and azelaic acid. The document emphasized the need for personalized treatment plans and further research to improve diagnostic criteria and management of acne and related conditions.